TITLE

Deneysel Kontrollü Non-Heart Beating Donor Modelinde Edaravonun Karaciğer Hasarını Önleyici Etkisi

AUTHOR(S)
Çetin, Mehmet Mustafa; Yılmaz, Zeki; Artış, Tarık; Deniz, Kemal; Saraymen, Recep
PUB. DATE
September 2012
SOURCE
Erciyes Medical Journal / Erciyes Tip Dergisi;2012, Vol. 34 Issue 3, p127
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: The aim of this study is to investigate the effect of Edaravone on viability of hepatocytes in experimental controlled non-heart beating donor models of rats and additionaly to determine the usefullness of these grafts. Material and Methods: Forty Wistar-Albino male rats, 225-290 grams in weight were randomly assigned to five different groups (sham, two control and two study groups). Cardiac arrest was performed by intracardiac KCl injection (0.2 mL). Livers were subjected to 30 minutes of warm ischemia and were washed out with 50 mL Euro Collins solution via a portal vein catheter after total hepatectomy. Liver grafts in the control groups and the study groups were perfused with Histidin-Tryptophan-Ketoglutarat solution including SF and edaravone (1 mg/kg), respectively. The perfusion was lasted for 30 or 60 min using a circulatory system. AST, ALT, IL-10, IL-6, TNF-α levels were measured in the perfusion fluids. The grafts were saved under suitable conditions for histopathological assessment. Results: It was found that the Edaravone Groups have lower levels of AST, ALT, IL-6, and TNF-α and have higher levels of IL-10, PCNA labeling index, and Bcl-2 staining index when compared to Control Groups. Conclusion: Edaravone increases the viability of hepatocytes biochemically, morphologically in experimental controlled non-heart beating donor models of rats.
ACCESSION #
83241239

 

Related Articles

  • Ameliorating effects of two extracts of Nigella sativa in middle cerebral artery occluded rat. Akhtar, Mohammad; Maikiyo, Aliyu Muhammad; Khanam, Razia; Mujeeb, Mohd; Aqil, Mohd; Najmi, Abul Kalam // Journal of Pharmacy & Bioallied Sciences;Jan-Mar2012, Vol. 4 Issue 1, p70 

    Purpose: Aqueous and hydroalcoholic extracts of Nigella sativa (400 mg/kg, orally) for 7 days were administered and evaluated for their neuroprotective effects on middle cerebral artery occluded (MCAO) rats. Materials and Methods: Cerebral ischemia was induced by middle cerebral artery occlusion...

  • Radio-neuroprotective effect of L-alpha-glycerylphosphorylcholine (GPC) in an experimental rat model. Plangár, Imola; Szabó, Emília; Tőkés, Tünde; Mán, Imola; Brinyiczki, Kitti; Fekete, Gábor; Németh, István; Ghyczy, Miklós; Boros, Mihály; Hideghéty, Katalin // Journal of Neuro-Oncology;Sep2014, Vol. 119 Issue 2, p253 

    Ionizing radiation plays a major role in the treatment of brain tumors, but side-effects may restrict the efficacy of therapy. In the present study, our goals were to establish whether the administration of L-alpha-glycerylphosphorylcholine (GPC) can moderate or prevent any of the...

  • Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury. Cui, Changmeng; Cui, Ying; Gao, Junling; Sun, Liqian; Wang, Yongchao; Wang, Kaijie; Li, Ran; Tian, Yanxia; Song, Sixin; Cui, Jianzhong // Neurological Sciences;May2014, Vol. 35 Issue 5, p695 

    Traumatic brain injury (TBI) is a leading cause of mortality and disability in children and young adults worldwide. Neurologic impairment is caused by both immediate brain tissue disruption and post-injury cellular and molecular events that worsen the primary neurologic insult. The β-lactam...

  • Chlorpromazine Protects Against Apoptosis Induced by Exogenous Stimuli in the Developing Rat Brain. Jing Wu; Rongrong Song; Wuqi Song; Yujun Li; Qingmeng Zhang; Yang Chen; Yingmei Fu; Wenjuan Fang; Jindong Wang; Zhaohua Zhong; Hong Ling; Liming Zhang; Fengmin Zhang // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: Chlorpromazine (CPZ), a commonly used antipsychotic drug, was found to play a neuroprotective role in various models of toxicity. However, whether CPZ has the potential to affect brain apoptosis in vivo is still unknown. The purpose of this study was to investigate the potential...

  • Influence of heme oxygenase-1 expression on immune liver fibrosis induced by cobalt protoporphyrin in rats. Fei Wang; Zhi-Jun Duan; Ying-Jie Sun; Grizzi, Fabio // World Journal of Gastroenterology;6/28/2009, Vol. 15 Issue 24, p3009 

    AIM: To investigate the effect of heme oxygenase-1 (HO-1) expression on immune liver fibrosis induced by cobalt protoporphyrin (CoPP) in rats. METHODS: An immune liver fibrosis model of rat was established by administering human serum albumin (HSA). The rats were divided into CoPP, liver...

  • KaraciÄŸer ve böbrek üzerine etanolün toksisitesi ve L-NAME' in koruyucu etkisi. Kutlubay, Recep; Oğuz, Emin Oğuzhan; Turgut, Günfer; Kocamaz, Erdoğan // Medical Journal of Suleyman Demirel University;Dec2008, Vol. 15 Issue 4, p11 

    Aim: To show the histological liver and renal damage caused by ethanol at a certain dose and to show possible protective role of L-NAME. Materials and Methods: In this study, 40, 6 month-old Wistar rats were randomly divided into four groups: I- Control (n=10) II- Etanol (n=10) III-L-NAME (n=10)...

  • Role of Vitamin-E on Rat Liver-amiodarone: An Ultrastructural Study. Zaki, Mohamed Samir A.; Eid, Refaat A. // Saudi Journal of Gastroenterology;Apr2009, Vol. 15 Issue 2, p104 

    Background/Aim: Amiodarone, a class III antiarrhythmic drug, has been found to be effective in the management of patients with life-threatening ventricular arrhythmias. The aim of this study was to test whether the co administration of vitamin-E with amiodarone can reduce amiodarone-induced...

  • Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies. Diaz, F.; Garcia, S.; Hernandez, D.; Regev, A.; Rebelo, A.; Oca-Cossio, J.; Moraes, C. I. // Gut;Feb2008, Vol. 57 Issue 2, p232 

    Background: Although oxidative phosphorylation defects can affect the liver, these conditions are poorly under- stood, partially because of the lack of animal models. Aims: To create and characterise the pathophysiology of mitochondrial hepatopathies in a mouse model. Methods: A mouse model of...

  • Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. Kaji, Kosuke; Yoshiji, Hitoshi; Ikenaka, Yasuhide; Noguchi, Ryuichi; Aihara, Yosuke; Douhara, Akitoshi; Moriya, Kei; Kawaratani, Hideto; Shirai, Yusaku; Yoshii, Junichi; Yanase, Koji; Kitade, Mitsuteru; Namisaki, Tadashi; Fukui, Hiroshi // Journal of Gastroenterology;Mar2014, Vol. 49 Issue 3, p481 

    Background: Dipeptidyl peptidase-4 inhibitor (DPP4-I) is clinically used as a new oral antidiabetic agent. Although DPP4 is reportedly associated with the progression of chronic liver diseases, the effect of DPP4-I on liver fibrosis development is still obscure. This study was designed to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics